HEPACAM and prostate carcinoma: Expression of hepaCAM was inversely related to the HOTAIR in prostate cancer due to repression of hepaCAM promotor by HOTAIR-mediated recruitment of PRC2 and downregulation of hepaCAM promoted metastasis by the abnormal activation of MAPK signalling pathway.